Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NVO
NVO logo

NVO News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NVO News

Viking Plans to Advance VK2735 Oral Drug

11h agostocktwits

Investment Opportunities in Healthcare Stocks

13h agoFool

Pfizer and Novo Nordisk Stock Attractiveness Analysis

13h agoNASDAQ.COM

Novo Nordisk Receives Warning Letter from FDA

14h agoseekingalpha

Hims & Hers Receives Upgrade Following Novo Nordisk Agreement, But Stock Gains May Remain Constrained.

14h agoBarron's

Hims & Hers Shares Raised Following Novo Nordisk Deal: Reasons to Hold Off on Buying.

14h agoBarron's

European Natural Gas Prices Hit Three-Year High Amid Geopolitical Tensions

15h agoBenzinga

BofA Nearly Doubles HIMS Price Target to $23 Following Novo Deal

16h agostocktwits

NVO Events

03/10 16:20
Major Averages Close Little Changed as Oil Prices Pull Back
The major averages closed little changed as markets traded with a more constructive tone in concert with oil prices pulling back. Oil prices, which had surged above $100 and briefly approached $120 per barrel during the escalation of the Iran conflict, are now coming back in after comments from Donald Trump suggesting the military operation could conclude sooner than previously expected. Meanwhile, CBS News' Jennifer Jacobs reported that there are indications Iran is taking steps to deploy mines in the Strait of Hormuz.In other commodity news, gold prices continue their surge amid market volatility. Despite having an up-and-down 2026, the commodity is climbing towards record highs once again.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiaand Thinking Machines Lab announced a gigawatt-scale strategic partnershipBioNTechannounced plans for anto be established and led by BioNTech co-founders Prof. Ugur Sahin, M.D., and Prof. Ozlem Tureci, M.D.HP Enterprisereportedand provided guidance for Q1 and FY26Kohl'sreportedbut guided for a decrease in Q1 comp salesVail Resortsreportedand cut its FY26 resort reported EBITDA view2. WALL STREET CALLS:Qualcommat Underperform at BofACrowdStriketo Overweight at Morgan StanleyRivianto Buy at TD Cowen into R2 launchNovo Nordiskto Hold at TD CowenB. RileyStrategywith Buy on "unmatched scale"3. AROUND THE WEB:Boeingwill delay deliveries of some e737 MAX planes amid wiring flaws, WSJ reportsExxon Mobilis planning to move its legal home to Texas from New Jersey in a move meant to protect the company from shareholder "abuse," WSJ saysRio Tintois in talks with Mongolia over financial terms at the massive Oyu Tolgoi copper mine, with the government seeking lower loan interest costs and the removal of Rio's annual management fee, WSJ reportsAppleincreased its iPhone production in India by 53% last year and now makes a total of 25% of its devices there, Bloomberg saysAmazon'secommerce business has requested a large group of engineers to meet on Tuesday for a "deep dive" into the influx of outages, with the company stating there has been a "trend of incidents" characterized by a "high blast radius" and "Gen-AI assisted changes," FT reports4. MOVERS:Zevra Therapeuticsgains after, with EPS and revenue beating consensusCapricorincreases after announcing the establishment of a new PDUFANiohigher in New York afterand providing guidance for Q1Centenefalls afterand announcing its ACA enrollment is "still in line" with expectations"Crispr Therapeuticslower after announcing a5. EARNINGS/GUIDANCE:ABM, with CEO Scott Salmirs commenting, "ABM is off to a solid start to FY26"Custom Truck One Source, with EPS beating consensusUnited Natural Foodsand provided guidance for FY26UWM Holdingsraised itsPriority Technologyand provided guidance for FY26INDEXES:The Dow fell 34.29, or 0.072%, to 47,706.51, the Nasdaq gained 1.16, or 0.0051%, to 22,697.10, and the S&P 500 advanced 14.51, or 0.21%, to 6,781.48.
03/10 12:00
Major Averages Rise as Oil Prices Retreat Below $100
The major averages were higher near noon as markets are trading with a more constructive tone. Investors are reacting to a reversal in the energy shock that dominated markets earlier in the week. Oil prices, which had surged above $100 and briefly approached $120 per barrel during the escalation of the Iran conflict, are now pulling back after comments from Donald Trump suggesting the military operation could conclude sooner than previously expected.Meanwhile, gold prices continue their surge amid market volatility, as the "safe haven" asset rose nearly 2%. Despite having an up-and-down 2026, the commodity is climbing towards record highs once again.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiaintends to launch an open-source AI agent platform,BioNTechannounced plans forto be established and led by BioNTech co-founders Prof. Ugur Sahin, M.D., and Prof. Ozlem Tureci, M.D.HP Enterprisereportedand provided guidance for Q1 and FY26Kohl'sreportedbut guided for a decrease in Q1 comp salesVail Resortsreportedand cut its FY26 resort reported EBITDA view2. WALL STREET CALLS:Qualcommat Underperform at BofACrowdStriketo Overweight at Morgan StanleyRivianto Buy at TD Cowen into R2 launchNovo Nordiskto Hold at TD CowenB. RileyStrategywith Buy on "unmatched scale"3. AROUND THE WEB:Exxon Mobilis planning to move its legal home to Texas from New Jersey in a move meant to protect the company from shareholder "abuse," WSJ saysRio Tintois in talks with Mongolia over financial terms at the massive Oyu Tolgoi copper mine, with the government seeking lower loan interest costs and the removal of Rio's annual management fee, WSJ reportsAppleincreased its iPhone production in India by 53% last year and now makes a total of 25% of its devices there, Bloomberg saysAmazon'secommerce business has requested a large group of engineers to meet on Tuesday for a "deep dive" into the influx of outages, with the company stating there has been a "trend of incidents" characterized by a "high blast radius" and "Gen-AI assisted changes," FT reportsA groundstop for all JetBlueflights was canceled within an hour on Tuesday by the U.S. Federal Aviation Administration, FAA, after JetBlue said it resolved a "system outage," Reuters reports4. MOVERS:Zevra Therapeuticsgains after, with EPS and revenue beating consensusCapricorincreases after announcing the establishment of afor dermiocel BLANiohigher in New York afterand providing guidance for Q1Centenefalls afterfor FY26 and announcing its ACA enrollment is "still in line" with expectations"Crispr Therapeuticslower after announcing a5. EARNINGS/GUIDANCE:ABM, with CEO Scott Salmirs commenting, "ABM is off to a solid start to FY26"Custom Truck One Source, with EPS beating consensusUnited Natural Foodsand provided guidance for FY26UWM Holdingsfor Q1Priority Technologyand provided guidance for FY26INDEXES:Near midday, the Dow was up 0.48%, or 229.12, to 47,969.92, the Nasdaq was up 0.58%, or 131.24, to 22,827.19, and the S&P 500 was up 0.39%, or 26.81, to 6,822.80.
03/10 11:40
Novo Nordisk Shares Down with Mixed Options Sentiment
Mixed options sentiment in Novo Nordisk (NVO), with shares down $1.35 near $38.42. Options volume relatively light with 35k contracts traded and calls leading puts for a put/call ratio of 0.33, compared to a typical level near 0.71. Implied volatility (IV30) dropped 0.79 near 44.65,and below the 52wk median, suggesting an expected daily move of $1.08. Put-call skew flattened, suggesting a modestly bullish tone, following a downgrade to Hold at TD Cowen.
03/10 09:50
FDA Warns Novo Nordisk Over Failure to Report ADEs
In a warning letter to Novo Nordisk regarding its Plainsboro, NJ plant, the FDA said, "Specifically, you and your contractors inappropriately invalidated 15-day Alert reports due to a lack of patient identifiers; however, during the inspection, FDA identified valid patient identifiers in source documents for these reports. These reports were not submitted to FDA until they were discussed with you during the inspection. For example, Argus case 1342548 includes a consumer reporting a death for a male patient who received semaglutide, however you invalidated the case because you failed to capture the patient identifier. During the inspection, FDA found the patient identifier in the source documents for this case. As a result of this erroneous invalidation, you failed to report serious and unexpected ADEs to FDA within 15 calendar days as required."

NVO Monitor News

Novo Nordisk Invests $506 Million to Expand Manufacturing in Ireland

Mar 04 2026

Novo Nordisk Faces Challenges Amid Stock Decline

Mar 03 2026

Novo Nordisk Faces Investigation Amid Clinical Trial Failure

Mar 02 2026

Novo Nordisk Faces Challenges Amid Drug Price Cuts and Trial Failures

Feb 24 2026

Novo Nordisk faces stock pressure amid disappointing earnings and competition

Feb 23 2026

Novo Nordisk Faces Sales Decline Amid Market Competition

Feb 09 2026

Novo Nordisk Warns of Declining Sales Amid Market Competition

Feb 05 2026

Novo Nordisk's CagriSema Trial Results Show Competitive Edge

Feb 03 2026

NVO Earnings Analysis

Novo Nordisk Reports Strong H1 2025 Earnings, Obesity Growth- Intellectia AI™
7 months ago

People Also Watch